Falls City Limb & Brace Co Inc.

Falls City Limb & Brace Co Inc., doing business as Louisville Prosthetics, manufactures custom prosthetic limbs and components as a prime contractor exclusively to the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9), competing in full-and-open procurements with no set-aside designations.

Louisville Prosthetics is a for-profit manufacturer headquartered in Louisville, Kentucky, with primary performance locations in Louisville and Heritage Creek, Kentucky. The vendor has been registered in SAM.gov since March 2002. Across the NAICS footprint, the company's 282 prime awards split between Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (166 awards) and Surgical Appliance and Supplies Manufacturing (75 awards), with smaller volume in Surgical and Medical Instrument Manufacturing. PSC coding reflects Medical And Surgical Instruments, Equipment, And Supplies (156 awards) and maintenance/repair/rebuild of medical equipment (125 awards). All awards are firm fixed-price purchase orders, and the vendor performs all work in-house without subcontractors.

Customer concentration is absolute: VISN 9 accounts for 119 awards (42% of the 282 total) and $2.5 million in combined potential value across the entire portfolio, with no other agencies in the active set. The vendor sits on one named parent vehicle, Indefinite Delivery Contract V603P3355 (151 task orders, $881 thousand combined potential value), which is a VA-managed IDIQ for prosthetic devices. Representative recent awards include a $86,895 firm fixed-price order from VISN 9 on August 4, 2025, for an above-knee prosthesis with microprocessor knee and power foot; a $66,050 order from May 1, 2024, for multiple prosthetic limbs and components (above-knee and below-knee prostheses, sockets, and feet); and a $53,372 order from February 9, 2026, for a clinician-prescribed above-the-knee right prosthesis (HCPCS L5986).

Activity has declined in recent years. The vendor received ten awards in 2022, but fell to five awards in 2023, three in 2024, five in 2025, and two in early 2026. Combined potential value across all 282 awards totals $4.5 million, with $4 million obligated (89% realization). The vendor competes exclusively for veteran-specific prosthetic device procurements in open market conditions without set-aside protection, reflecting established standing with VISN 9 as a specialized prosthetics manufacturer supporting 38 U.S.C. § 8123 veteran healthcare delivery.